Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.46 EUR | +1.80% | +8.78% | -50.80% |
05-14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
05-14 | Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.80% | 1.97B | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+47.02% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- EVT Stock
- News Evotec SE
- Evotec Q3 Net Loss Narrows as Revenue Rises; Reaffirms 2023 Revenue Outlook